JP2010523596A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523596A5
JP2010523596A5 JP2010502341A JP2010502341A JP2010523596A5 JP 2010523596 A5 JP2010523596 A5 JP 2010523596A5 JP 2010502341 A JP2010502341 A JP 2010502341A JP 2010502341 A JP2010502341 A JP 2010502341A JP 2010523596 A5 JP2010523596 A5 JP 2010523596A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkylenyl
conr
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502341A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010523596A (ja
JP5347164B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/059505 external-priority patent/WO2008124651A2/en
Publication of JP2010523596A publication Critical patent/JP2010523596A/ja
Publication of JP2010523596A5 publication Critical patent/JP2010523596A5/ja
Application granted granted Critical
Publication of JP5347164B2 publication Critical patent/JP5347164B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502341A 2007-04-05 2008-04-04 ニトロ−イミダゾール低酸素造影剤 Expired - Fee Related JP5347164B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92193207P 2007-04-05 2007-04-05
US60/921,932 2007-04-05
US96425407P 2007-08-10 2007-08-10
US60/964,254 2007-08-10
PCT/US2008/059505 WO2008124651A2 (en) 2007-04-05 2008-04-04 Nitro-imidazole hypoxia imaging agents

Publications (3)

Publication Number Publication Date
JP2010523596A JP2010523596A (ja) 2010-07-15
JP2010523596A5 true JP2010523596A5 (enExample) 2011-05-12
JP5347164B2 JP5347164B2 (ja) 2013-11-20

Family

ID=39831553

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502341A Expired - Fee Related JP5347164B2 (ja) 2007-04-05 2008-04-04 ニトロ−イミダゾール低酸素造影剤

Country Status (7)

Country Link
US (2) US7807394B2 (enExample)
EP (1) EP2132200B1 (enExample)
JP (1) JP5347164B2 (enExample)
KR (1) KR101523257B1 (enExample)
CN (1) CN101652360B (enExample)
CA (1) CA2683433C (enExample)
WO (1) WO2008124651A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807394B2 (en) * 2007-04-05 2010-10-05 Siemens Medical Solutions Usa, Inc. Nitro-imidazole hypoxia imaging agents
CN101709060B (zh) * 2009-12-02 2013-05-01 北京师范大学 一种f-三唑环-聚乙二醇-甲硝唑化合物及其制备方法
MX388479B (es) 2010-02-08 2025-03-11 Lantheus Medical Imaging Inc Metodos y aparatos para sintetizar agentes formadores de imagen e intermedios de estos.
US10639608B2 (en) 2010-04-08 2020-05-05 Siemens Medical Solutions Usa, Inc. System, device and method for preparing tracers and transferring materials during radiosynthesis
JP6245981B2 (ja) 2010-04-08 2017-12-13 シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッドSiemens Medical Solutions USA,Inc. 含水有機溶媒中の18f−標識化トレーサーの合成
CN101921263A (zh) * 2010-04-16 2010-12-22 兰州大学 2-硝基咪唑衍生物及其用途和制备方法
KR102136503B1 (ko) 2010-05-11 2020-07-21 랜티우스 메디컬 이메징, 인크. 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
US9550000B2 (en) 2011-09-09 2017-01-24 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
JPWO2013054788A1 (ja) * 2011-10-14 2015-03-30 住友重機械工業株式会社 荷電粒子線照射システム及び荷電粒子線照射計画方法
US20150010474A1 (en) * 2011-12-23 2015-01-08 Auckland Uniservices Limited Compounds And Methods For Selective Imaging And/Or Ablation
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
WO2015104589A1 (en) 2014-01-13 2015-07-16 Shanghai Lawring Biomedical Co., Ltd Dendrimer compositions, methods of synthesis, and uses thereof
EP3199183A4 (en) * 2014-09-25 2018-02-21 Nihon Medi-Physics Co., Ltd. Renal imaging agent
US10695446B2 (en) 2015-05-01 2020-06-30 Vanderbilt University Composition and method for detecting hypoxia
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
CN106977501A (zh) * 2017-03-20 2017-07-25 华东师范大学 一种基于2‑硝基咪唑‑1‑烷基醇的低氧激活前药
FR3068695B1 (fr) 2017-07-05 2019-08-16 Centre National De La Recherche Scientifique Composes utiles comme agent d'imagerie de l'hypoxie
CN111372940A (zh) * 2017-09-19 2020-07-03 阿尔伯塔大学理事会 生物还原活化的化合物、其前药、放射性药物、组合物及其在包括癌症在内的低氧疾病的多模式治疗控制中的应用
WO2019056097A1 (en) * 2017-09-19 2019-03-28 The Governors Of The University Of Alberta MARKERS, CONJUGATES, COMPOSITIONS AND METHODS FOR IMAGING, CARTOGRAPHY AND THERAPY OF HYPOXIA
WO2021138540A1 (en) 2020-01-03 2021-07-08 Berg Llc Polycyclic amides as ube2k modulators for treating cancer
CN111233821B (zh) * 2020-01-20 2022-12-27 上海交通大学医学院附属仁济医院 含3-羟基苯甲酸基团的新抗霉素衍生物及其制备方法和应用
CN114478489B (zh) * 2022-01-18 2023-04-28 中国科学院精密测量科学与技术创新研究院 一种氟-19修饰的硝基咪唑化合物及其衍生物的制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674693A (en) * 1994-03-18 1997-10-07 Natural Pharmacia International Inc. Derivatives of 2-nitro-imidazoles as hypoxic cell markers
US5721265A (en) * 1994-08-05 1998-02-24 Sri International Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
JP2003507354A (ja) * 1999-08-11 2003-02-25 ユニべルシテ・カトリック・ドゥ・ルベン 細胞の低酸素症を検出するためのパーフルオロ化〔18f〕放射性同位体標識ニトロイミダゾール誘導体の製法
US7807394B2 (en) * 2007-04-05 2010-10-05 Siemens Medical Solutions Usa, Inc. Nitro-imidazole hypoxia imaging agents

Similar Documents

Publication Publication Date Title
JP2010523596A5 (enExample)
JP2009541403A5 (enExample)
JP2010504301A5 (enExample)
JP2010501534A5 (enExample)
JP2011506530A5 (enExample)
JP2010505891A5 (enExample)
HRP20140667T4 (hr) Nukleozid fosforamidat prolijekovi
JP2009529091A5 (enExample)
JP2009539914A5 (enExample)
JP2008515616A5 (enExample)
JP2011526312A5 (enExample)
LU92376I2 (fr) Alogliptin sous toutes ses formes telles que protégées par le brevet de base, combiné avec pioglitazone sous toutes ses formes telles que protégées par le brevet de base
JP2011136981A5 (enExample)
JP2009524695A5 (enExample)
JP2010524750A5 (enExample)
JP2009542225A5 (enExample)
JP2013527474A5 (enExample)
JP2012042477A5 (enExample)
JP2010529364A5 (enExample)
JP2013501834A5 (enExample)
JP2010285401A5 (enExample)
JP2011016798A5 (enExample)
JP2008513472A5 (enExample)
JP2006525972A5 (enExample)
JP2009075520A5 (enExample)